SMS Pharmaceuticals Limited (SMSPHARMA.BO)

INR 242.45

(2.08%)

Long Term Debt Summary of SMS Pharmaceuticals Limited

SMS Pharmaceuticals Limited's latest annual long term debt in 2023 was 1.22 Billion INR , up 0.28% from previous year.
SMS Pharmaceuticals Limited's latest quarterly long term debt in 2023 FY was 1.22 Billion INR , up 0.28% from previous quarter.
SMS Pharmaceuticals Limited reported annual long term debt of 1.21 Billion INR in 2022, down -19.7% from previous year.
SMS Pharmaceuticals Limited reported annual long term debt of 1.51 Billion INR in 2021, up 0.7% from previous year.
SMS Pharmaceuticals Limited reported quarterly long term debt of - INR for 2023 Q3, down -100.0% from previous quarter.
SMS Pharmaceuticals Limited reported quarterly long term debt of 1.13 Billion INR for 2023 Q2, down 0.0% from previous quarter.

Annual Long Term Debt Chart of SMS Pharmaceuticals Limited (2023 - 2004)

Historical Annual Long Term Debt of SMS Pharmaceuticals Limited (2023 - 2004)

Year	Long Term Debt	Long Term Debt Growth
2023	1.22 Billion INR	0.28%
2022	1.21 Billion INR	-19.7%
2021	1.51 Billion INR	0.7%
2020	1.5 Billion INR	106.25%
2019	730 Million INR	17.34%
2018	622.1 Million INR	-12.87%
2017	713.98 Million INR	-3.8%
2016	742.15 Million INR	-16.87%
2015	892.72 Million INR	8.49%
2014	822.86 Million INR	18.62%
2013	693.69 Million INR	29.34%
2012	536.35 Million INR	-34.47%
2011	818.42 Million INR	-9.12%
2010	900.56 Million INR	-44.86%
2009	1.63 Billion INR	19.0%
2008	1.37 Billion INR	49.62%
2007	917.29 Million INR	47.54%
2006	621.71 Million INR	-4.95%
2005	654.08 Million INR	4.11%
2004	628.23 Million INR	0.0%

Year	Long Term Debt	Long Term Debt Growth
2023 Q1	- INR	-100.0%
2023 Q3	- INR	-100.0%
2023 Q2	1.13 Billion INR	0.0%
2023 FY	1.22 Billion INR	0.28%
2023 Q4	1.22 Billion INR	0.0%
2022 Q3	- INR	-100.0%
2022 Q4	1.21 Billion INR	0.0%
2022 FY	1.21 Billion INR	-19.7%
2022 Q1	- INR	-100.0%
2022 Q2	1.33 Billion INR	0.0%
2021 Q4	1.51 Billion INR	0.0%
2021 Q1	- INR	-100.0%
2021 Q3	- INR	-100.0%
2021 Q2	1.3 Billion INR	0.0%
2021 FY	1.51 Billion INR	0.7%
2020 Q2	984.67 Million INR	0.0%
2020 FY	1.5 Billion INR	106.25%
2020 Q4	1.5 Billion INR	0.0%
2019 FY	730 Million INR	17.34%
2019 Q2	632.16 Million INR	0.0%
2019 Q4	730 Million INR	0.0%
2018 FY	622.1 Million INR	-12.87%
2018 Q4	622.1 Million INR	0.0%
2017 FY	713.98 Million INR	-3.8%
2016 Q2	1.03 Billion INR	0.0%
2016 FY	742.15 Million INR	-16.87%
2015 Q4	892.72 Million INR	0.0%
2015 FY	892.72 Million INR	8.49%
2015 Q2	1.07 Billion INR	0.0%
2014 Q4	822.86 Million INR	0.0%
2014 Q2	628.2 Million INR	0.0%
2014 FY	822.86 Million INR	18.62%
2013 Q4	693.69 Million INR	0.0%
2013 FY	693.69 Million INR	29.34%
2013 Q2	481.63 Million INR	0.0%
2012 FY	536.35 Million INR	-34.47%
2012 Q4	536.35 Million INR	0.0%
2011 FY	818.42 Million INR	-9.12%
2011 Q4	818.42 Million INR	0.0%
2010 FY	900.56 Million INR	-44.86%
2009 FY	1.63 Billion INR	19.0%
2008 FY	1.37 Billion INR	49.62%
2007 FY	917.29 Million INR	47.54%
2006 FY	621.71 Million INR	-4.95%
2005 FY	654.08 Million INR	4.11%
2004 FY	628.23 Million INR	0.0%

Peer Long Term Debt Comparison of SMS Pharmaceuticals Limited

Name	Long Term Debt	Long Term Debt Difference
Abbott India Limited	367.6 Million INR	-232.117%
Cipla Limited	2.25 Billion INR	45.841%
Gland Pharma Limited	1.06 Billion INR	-14.592%
GlaxoSmithKline Pharmaceuticals Limited	64.69 Million INR	-1787.222%
Kopran Limited	166.02 Million INR	-635.34%
Marksans Pharma Limited	1.9 Billion INR	35.75%
NGL Fine-Chem Limited	7.44 Million INR	-16291.823%
Pfizer Limited	543.5 Million INR	-124.63%
Sanofi India Limited	139 Million INR	-778.319%